Thomas W Beetham - EVP & Chief Legal Officer, Kiniksa Pharmaceuticals, Ltd

As of March 23, 2021


Thomas W Beetham Net Worth

  • Net worth is estimated to be at least $3.27M
  • Owns at least 297,523 units of Kiniksa Pharmaceuticals, Ltd stock
  • Sold an estimated value of $2.11M in the last 3 years at Kiniksa Pharmaceuticals, Ltd

Thomas W Beetham Compensation at Kiniksa Pharmaceuticals, Ltd in 2020

  • Earned a $440,000 salary
  • Received a total compensation of $2,291,573

Thomas W Beetham Trading

  • Largest purchase of shares was 13,752 units , worth over $21.87K on June 12, 2020
  • Largest sale of shares was 49,941 units , worth over $953.97K on April 22, 2020
  • In total has made about 13 transactions over 3 years
  • Usually trades in March, with the busiest year in 2020
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Thomas W Beetham Mailing Address

  • Mailing address is C/o Kiniksa Pharmaceuticals, Ltd. Clarendon House, 2 Church Street Hamilton D0 HM11 Bermuda

Kiniksa Pharmaceuticals, Ltd Executive Compensation

Name
Year
Salary
Other Earnings Plans or Compensations
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Sanj K. Patel 2020 $780,000 $633,750 $3,888,414 $633,750 $11,400 $5,313,564
Sanj K. Patel 2019 $780,000 $456,300 $3,518,171 $456,300 $11,200 $4,765,671
Thomas Beetham 2020 $440,000 $220,000 $1,620,173 $220,000 $11,400 $2,291,573
Qasim Rizvi, MBChB., MBA 2020 $431,970 $188,987 $1,620,173 $188,987 $11,400 $2,252,530
Qasim Rizvi, MBChB., MBA 2019 $392,700 $123,701 $880,884 $123,701 $11,200 $1,503,573
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1730430/000110465921056540/tm212498-1_def14a.htm

Kiniksa Pharmaceuticals, Ltd Insider Trading

  • The most recent transaction was 56,159 units sold on February 10, 2021 by Sanj K Patel worth over $1.29M
  • In the last 3 years, insiders at Kiniksa Pharmaceuticals, Ltd sold an estimated value of $10.21M and bought an estimated value of $71.77M
  • The most active traders are John F Paolini, Chief Medical Officer,  Thomas W Beetham, EVP & Chief Legal Officer,  and Sanj K Patel, Chairman & CEO
  • Insider trading is most common in March, with the busiest year in 2021

Kiniksa Pharmaceuticals, Ltd. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1